BMC Cancer Oncology

Androgen receptor expression, the AR/ER ratio, and progression-free survival in hormone receptor-positive/HER2-negative metastatic breast cancer treated with CDK4/6 inhibitors

Aysun Fatma Akkuş, Ebru Taştekin, Gökhan Öztürk, Tayyip İlker Aydın, Bülent Erdoğan, Ahmet Küçükarda, Onur Yıldırım, Muhammet Bekir Hacıoğlu, Sernaz Topaloğlu
Springer Nature · 2026-10-31 · DOI 10.1186/s12885-026-17310-6

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →